Rescare INC (DBA Brightspring Health Services)
Workforce Development/Training, Community Based Services, Healthcare
Based in KY
🤖
AI Overview
With $1.3M in lobbying spend across 32 quarterly filings, Rescare INC (DBA Brightspring Health Services) is a significant lobbying presence. Their lobbying covers 7 issue areas. Active from 2018 to 2025.
$1.3M
Total Spend
8
Years Active
1
Firms Hired
8
Lobbyists Deployed
7
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $120K |
| 2019 | $120K |
| 2020 | $150K |
| 2021 | $180K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $240K |
| 2025 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Medicare/Medicaid, Labor Issues, Veterans, Small Business and 2 more
- •Monitored P.L.115-141, Consolidated Appropriations Act, 2018
- •Discussions involving Medicaid coverage of monitoring technology to improve in-home care
- •Monitored discussions involving working requirements for recipients of public benefits
- •Discussions involving workforce training
- •Monitored discussions involving working requirements for recipients of public benefits
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.